Evaluation of Two Reduced Sirolimus Doses in Treatment of de Novo Coronary Artery Lesions (REDOX)

Clinical trial NCT00233766 · COMPLETED

Trial details

NCT number: NCT00233766
Sponsor: Cordis US Corp.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2002-09-01
Primary completion: 2007-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.